Clinical case of transitional cell carcinoma of the ovary as a problem of the imperfection of the screening strategy
Keywords:
transitional cell tumor, magnetic resonance imaging, oncomarkers, ultrasound diagnosticsAbstract
Transitional cell tumors of the ovary are quite rare neoplasms and there is currently no single treatment strategy for this
pathology. However, among gynecological malignant neoplasms, ovarian cancer has the highest mortality rate. Due to the lack
of effective screening programs, only in 20% of cases it is possible to diagnose at stage I and II of the disease. Thus, early
diagnosis is a challenge for oncologists around the world.
This article presents a clinical case of the problem of primary diagnosis of transitional cell carcinoma, for the analysis,
which we conducted a literature review of the main methods of diagnosis of malignant tumors.
References
Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. MolCell Proteomics 2004; 3:355±66. https://doi.org/10.1074/mcp.R400006-MCP200 PMID: 14764655
Сеausu M., Terzea D., Georgescu A.et al. Transitional cell tumor of the ovary:a compact group with a heterogeneous histological and immunophenotypical pattern. Roman J Morphol Embryol 2008;49(4):513–6.
Kitajima K., Hayashi M., Kuwata Y.et al. MRI findings of transitional cell carcinoma of the ovary. Eur J Radiol Extra 2006;57(1):27–30.
Ziadi S., Trimeche M., Hidar S. et al. Bilateral Brenner tumor of the ovary associated with recurrent urothelial carcinoma of the urinary bladder. N Am JMed Sci 2010;1:39–41.
Gentry-Maharaj A, Sharma A, Burnell M, Ryan A, Amso NN, Seif MW, et al. Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Ultrasound in Obstetrics & Gynecology. 2013;41(1):73-79
Yamamoto R., Fujita M., Kuwabara M.et al. Malignant Brenner tumors of the ovary and tumor markers: case reports. Japan J Clin Oncol 1999;29(6):308–13.
Buys SS, Partridge E, Black A. Effect of screening on ovarian cancer mortality: The prostate,lung, colorectal and ovarian (plco) cancer screening randomized controlled trial. Journal of the American Medical AssociationJAMA. 2011;305(22):2295-2303
Buys SS, Partridge E, Black A. Effect of screening on ovarian cancer mortality: The prostate,lung, colorectal and ovarian (plco) cancer screening randomized controlled trial. Journal of the American Medical AssociationJAMA. 2011;305(22):2295-2303
Brenner tumour. www.radiopaedia.org
Cui YF, Li WH, Zhu MJ, et al. Clinical application and research of diffusion weighted MR imaging in complex ovarian tumors. Journal of China Clinic Medical Imaging. 2012; 23: 856–859.
Dolgushin BI, Tyurin IE, Luk’yanchenko AB, Medvedeva BM, Dronova EL, Shima V, et al. Standards of CT- and MRI contrast enhancement studies in oncology using. Medical Alphabet. 2013; 23 (3–4): 29–37. (In Russian).
Solomatina AA, Tyumentseva MYu, Shabrina OV, Shirinova SS, Sargsyan Исследования и практика в медицине. 2017, Т. 4, №1, с. 40-48 Research’n Practical Medicine Journal. 2017, V. 4, №1, p. 40-48 NS. The role of additional methods of examination in diagnosing small ovarian neoplasms.Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2008; 7 (5): 34–40. (In Russian).
Manganaro L, Bernardo S, Sergi M, Sollazzo P, Vinci V, De Grazia A, et al.Burkitt’s lymphoma presented as advanced ovarian cancer without evidence of lymphadenopathy: CT and MRI findings. Case Rep Radiol. 2013; 2013: 1–5. DOI: doi.org/10.1155/2013/940160.
Tsili A, Tsampoulas C, Argyropoulou M, Navrozoglou I, Alamanos Y, ParaskevaidisE, et al. Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses. Eur Radiol. 2008; 18 (5): 1049–1057. DOI: 10.1007/s00330–007–0842–4
Additional Files
Published
How to Cite
Issue
Section
License
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
